Newsroom | 61344 results

EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the first time in a human clinical setting, the dynamic role of the immune system in response to radioligand therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).1 The study, conducted in collaboration with RadioMedix, Inc....

MADISON, Wis.--(BUSINESS WIRE)--Promega will distribute NimaGen's IDseek® MPS library prep kits for forensic casework through a new distribution agreement with NimaGen....

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...

LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health, Inc. (“Valo”), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. In this role, Dr. Anagnostopoulos will lead the advancement of Valo’s human causal biology platform, translating large-scale, real‑world human data into causal insights that inform drug discovery. Valo aims to improve c...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for a grant to create training content for healthcare providers to deliver investigational COMP360 psilocybin treatment, if approved. Many high-quality training organizations already exist and have trained thousands of HCPs in core and psilocybin...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies for patients with Alzheimer’s disease (AD) and related neurodegenerative disorders, today announced it will present new clinical, safety, imaging, and biomarker findings, as well as brain edema (ARIA-E) and brain microhemorrhage (ARIA-H) for its lead investigational therapy, valiltramiprosate/ALZ-801, at the American Academy of Neurology (AAN) Annual Meeting in Chic...

OXFORD, England--(BUSINESS WIRE)--ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases. Under the agreement, ProImmune’s Ankyrons will be evaluated as molecular tools to enable precise detection, locali...

CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....

ロンドン--(BUSINESS WIRE)--（ビジネスワイヤ） -- オムディアの最新調査によると、2026年第1四半期のデスクトップPC、ノートブックPC、ワークステーションの総出荷台数は、前年同期比3.2%増の6,480万台となった。ノートブックPC（モバイルワークステーションを含む）の第1四半期の出荷台数は5,080万台を記録し、前年同期比2.6%の微増となった。一方、デスクトップPC（デスクトップ・ワークステーションを含む）は、それを上回る伸びで5.4%増の1,400万台となった。この成長には、部材コスト上昇が広く予想される中でベンダーやチャネルパートナーが発注を前倒ししたこと、商用リフレッシュ予算を引き続き牽引するWindows 10リプレース・サイクルの継続、そしてWindows系OEMとApple社の双方で例年より多い春の新製品投入が重なったことに支えられた。 「サプライチェーンへの圧力が依然として高まりをみせるなか、第1四半期の緩やかな成長が、今年のピークとなる可能性が高いといえます。」と、オムディアの主席アナリストであるBen Yeh氏は述べた。「メモリおよびスト...

SAN DIEGO--(BUSINESS WIRE)--U.S. FDA approves FILSPARI (sparsentan) for FSGS...